Ipca Laboratories Limited (BOM:524494)
India · Delayed Price · Currency is INR 1,747.15
-14.35 (-0.81%)
At close: Jul 31, 2026
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 443.42 billion as of July 31, 2026. Its market cap has increased by 14.27% in one year.
Market Cap
443.42B
Enterprise Value
454.16B
Revenue
96.47B
Ranking
n/a
PE Ratio
38.86
Stock Price
1,747.15
ChartMarket Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 443.42B, an increase of 13,676.29%. That is a compound annual growth rate of 22.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 443.42B | 23.18% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lupin | 1.10T |
| Dr. Reddy's Laboratories | 955.93B |
| Abbott India | 590.39B |
| GlaxoSmithKline Pharmaceuticals | 449.51B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 245.64B |
| Granules India | 204.20B |
| AstraZeneca Pharma India | 202.59B |